Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2016

Aug 3, 2016

29841_dirs_2016-08-03_ab7a3ee3-4021-42ae-9290-b047bf918e09.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2016-08-01

Reporting Person: Lerman Bradley E (SVP General Counsel & Corp Sec)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-08-01 Ordinary Shares A 11356 Acquired 52081 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-08-01 Stock Option (Right to Buy) $88.06 A 45424 Acquired 2026-08-01 Ordinary Shares (45424) Direct
2016-08-01 Stock Option (Right to Buy) $88.06 A 1136 Acquired 2026-08-01 Ordinary Shares (1136) Direct

Footnotes

F1: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2019 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee.

F2: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.